Healthequity Stock Performance

HQY
 Stock
  

USD 61.68  1.11  1.83%   

Healthequity has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.6837, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Healthequity's beta means in this case. As returns on the market increase, Healthequity returns are expected to increase less than the market. However, during the bear market, the loss on holding Healthequity will be expected to be smaller as well. Although it is important to respect Healthequity current price history, it is better to be realistic regarding the information on the equity's current price movements. The philosophy in determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Healthequity technical indicators, you can presently evaluate if the expected return of 0.15% will be sustainable into the future. Healthequity right now retains a risk of 2.58%. Please check out Healthequity value at risk, and the relationship between the information ratio and kurtosis to decide if Healthequity will be following its current trending patterns.
  
Healthequity Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Healthequity are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly sluggish basic indicators, Healthequity may actually be approaching a critical reversion point that can send shares even higher in September 2022. ...more

Healthequity Price Channel

Quick Ratio2.10
Fifty Two Week Low36.81
Target High Price95.00
Fifty Two Week High73.29
Target Low Price59.00

Healthequity Relative Risk vs. Return Landscape

If you would invest  5,724  in Healthequity on May 16, 2022 and sell it today you would earn a total of  444.00  from holding Healthequity or generate 7.76% return on investment over 90 days. Healthequity is generating 0.1515% of daily returns assuming volatility of 2.5828% on return distribution over 90 days investment horizon. In other words, 22% of stocks are less volatile than Healthequity, and above 98% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Healthequity is expected to generate 2.06 times more return on investment than the market. However, the company is 2.06 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The DOW is currently generating roughly 0.06 per unit of risk.

Healthequity Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Healthequity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Healthequity, and traders can use it to determine the average amount a Healthequity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0586

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
HQYHigh
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 2.58
  actual daily
 
 22 %
of total potential
 
2222
Expected Return
 0.15
  actual daily
 
 2 %
of total potential
 
22
Risk-Adjusted Return
 0.06
  actual daily
 
 4 %
of total potential
 
44
Based on monthly moving average Healthequity is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Healthequity by adding it to a well-diversified portfolio.

About Healthequity Performance

To evaluate Healthequity Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Healthequity generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Healthequity Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Healthequity stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Healthequity's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(0.94) (0.96) 
Return on Average Assets(0.014) (0.0144) 
Return on Average Equity(0.024) (0.0246) 
Return on Invested Capital(0.026) (0.0267) 
Return on Sales(0.04) (0.0411) 
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Things to note about Healthequity

Checking the ongoing alerts about Healthequity for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Healthequity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Healthequity Alerts

Equity Alerts and Improvement Suggestions

The company reported the last year's revenue of 778.03 M. Reported Net Loss for the year was (55.31 M) with profit before taxes, overhead, and interest of 423.71 M.
Latest headline from www.gurufocus.com: HealthEquity Sets Date to Announce Second Quarter Results Presentation at Conference - GuruFocus.com
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.